Professor
Barry Reed
55 lectures, 10 tutorials and 30 hours of practical work.
The aim of the subject is to provide students with a detailed knowledge of the
interaction between the dosage form and the patient and to provide a knowledge
of the factors affecting drug product stability.
In this teaching program students are expected to develop:
Dosage
form design. Formulation of injectables, preformulation, containers and
closures, pharmaceutical principles for products of biotechnology.
Drug stability. Shelf-life, storage conditions, accelerated stability
testing, stability trial design; chemical stability, pH-rate profiles,
hydrolysis, profiles of esters and amides; oxidation, photolysis; strategies
for stabilisation, stability issues for proteins.
Applied pharmacokinetics. Model-independent pharmacokinetics,
physiological modelling, drug metabolism, non-linear pharmacokinetics, drug
dosage in renal failure, drug dosage in liver disease, kinetics of
haemodialysis, multi-dose pharmacokinetics, pharmacokinetics in pregnancy,
effects of age, drugs in milk.
Drug interactions. Pharmacokinetics of drug interactions involving
absorption, distribution, metabolism and excretion.
Practical classes are designed to provide experience in sterile dispensing, formulation exercises and biopharmaceutics.
Recommended texts
Florence A T and Atwood D Physicochemical principles of
pharmacy 2nd edn, Macmillan, 1988
Shargel L and Yu A B C Applied biopharmaceutics and pharmacokinetics 3rd
edn, Appleton and Lange, 1993
Students should also retain textbooks utilised in earlier years of the course
Reference books
Banker G S and Rhodes C T Modern pharmaceutics 3rd edn,
Marcel Dekker, 1996
Gibaldi M Biopharmaceutics and clinical pharmacokinetics 4th edn, Lea
and Febiger, 1991
Rowland M and Tozer T N Clinical pharmacokinetics: Concepts and
applications 3rd edn, Williams and Wilkins, 1995
Subject assessment will reflect the learning objectives outlined above. Methods of assessment will include: